AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics Pain Program Update , page-50

  1. 5,803 Posts.
    lightbulb Created with Sketch. 335
    "I think any thought of self-financing Phase 3 have evaporated. A deal will be struck ahead of Phase 3 trials."

    Jev it may be this very reason that the trial has been varied? To demonstrate efficacy to potential big check signers?

    Why spend $20mill when you can do it for $5mill?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $20.06K 10.03M

Buyers (Bids)

No. Vol. Price($)
33 32398999 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 46150696 25
View Market Depth
Last trade - 13.15pm 13/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.